DVA:NYSE, DaVita Inc.

DVA stock overview

DaVita Inc. (DVA:NYSE) closed at $161.03 on November 20, 2026, up 3.00% on the day. The stock trades 34.9% below its 52-week high of $247.49 and 59.4% above its 52-week low of $101.00. Over the past year, it gained 33.9%. DaVita Inc. is part of the Health Care sector (Misc Health and Biotechnology Services).

Key figures

Price
$161.03
Day change
+3.00%
Volume
730,122
Average volume
737,178
Market cap
10B+
52-week range
$101.00 – $247.49
50-day average
$181.39
200-day average
$181.75

Price action over the past year

In 252 trading sessions since November 20, 2025, DVA closed higher on 131 days (52%). Its best day was May 6, 2026 (+23.46%) and its worst was August 5, 2026 (-17.24%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

DVA news

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2016, it provided dialysis and administrative services in the United States through a network of 2,350 outpatient dialysis centers serving approximately 187,700 patients; and operated 154 outpatient dialysi...

Similar stocks

Find more stocks like DVA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.